The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

Breaking News: FDA Approves New Treatment for Hep C (Genotype 1)

Back to News Homepage

Next

Patient Enrollment Started in the Phase II HELIX-2 Clinical Trial

Exciting Development in Search for Hepatitis C Vaccine

December 3, 2013

Print this page

By way of protein analysis, scientists at The Scripps Research Institute (TSRI) are forging ahead in the race to create a Hepatitis C vaccine.

Protein Analysis Could Lead To Hepatitis C Vaccine

redOrbit Staff & Wire Reports – Your Universe Online

A hepatitis C vaccine is one step closer thanks to the efforts of scientists at The Scripps Research Institute (TSRI), who have managed to discover unexpected structural features of a protein used by the virus to infect liver cells.

The study authors, whose work appears in Friday’s edition of the journal Science, state any successful hepatitis C vaccine would most likely target this protein, which is known as E2 envelope glycoprotein. Rare antibodies capable of binding E2 in ways that can neutralize a vast array of different viral strains have already been isolated in patients by scientists, they added.

Continue reading this entire article:
http://www.redorbit.com/news/health/1113016286/hepatitis-c-protein-analysis-e2-envelope-glycoprotein-113013/

No Comments - be the first!
Share
Share

Previous

Breaking News: FDA Approves New Treatment for Hep C (Genotype 1)

Back to News Homepage

Next

Patient Enrollment Started in the Phase II HELIX-2 Clinical Trial

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.